Papers

5

Total Citations

164

H-Index

4

About

Dr. Raizo Yamaguchi is a pioneering robotic surgeon whose work is reshaping urologic oncology and minimally invasive surgery. His most impactful contribution is the preclinical and clinical validation of the **Hinotori Surgical Robot System**, a novel Japanese-made platform. His landmark 2022 study (106 citations) demonstrated its safety and efficacy in complex urologic procedures, positioning Hinotori as a major competitor to established systems. Beyond platform validation, Dr. Yamaguchi has advanced **surgical planning** through computational tools; his 2015 work (41 citations) on virtual partial nephrectomy analysis showed how 3D color-coded models can accurately predict surgical outcomes, enabling more precise, nephron-sparing surgery. He has also contributed to **robot-assisted radical cystectomy** for bladder cancer and is exploring **Aquablation** for benign prostatic hyperplasia. Most recently, Dr. Yamaguchi is integrating **machine learning** to predict lymph node metastasis in prostate cancer, aiming to reduce unnecessary dissections. With a career spanning from preclinical innovation to clinical translation and AI-driven personalization, Dr. Yamaguchi stands at the forefront of the next generation of robotic urology.

Research Focus

Key Achievements

4
H-Index
5
Papers
164
Total Citations
33
Avg Citations/Paper
🏆 Most Cited Paper
Hinotori Surgical Robot System, a novel robot‐assisted surgical platform: Preclinical and clinical evaluation
106 citations · 2022
📈 Most Prolific Year: 2024 (2 Papers)
🤝 Key Collaborators: 44
🏛 Institutions: Kobe University Hospital, Teikyo University Hospital, Teikyo University, Kobe University

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago